Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Angiotensin (1-7) Experimental Workflows
2026-09-16
Build reproducible Mas-receptor experiments with a defined heptapeptide sequence, practical dosing benchmarks, and assay-ready handling guidance. From renal fibrosis models to receptor-binding studies, this workflow connects mechanism, controls, and troubleshooting without overstating translational evidence.
-
Reserpine (N1867): Practical Lab Workflow
2026-09-15
Reserpine (SKU N1867) provides a characterized research reagent for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and related neuropharmacology research. This guide addresses identity, solubility, storage, solution preparation, and QC; the compound is for research use only and should not be used for diagnostic, therapeutic, or medical applications.
-
Crizotinib Hydrochloride in ALK Research
2026-09-15
Crizotinib hydrochloride is an ATP-competitive ALK kinase inhibitor that also targets c-Met and ROS1. Its defined kinase-phosphorylation effects make it useful for cancer biology research, including controlled studies in patient-derived tumor–stroma models.
-
Preserving Protein Truth in Mitocytosis Research
2026-09-14
Mitocytosis research shows why biological interpretation depends on rigorous protein preservation. This thought-leadership guide connects mitochondrial stress biology with practical sample-preparation strategy, highlighting how an EDTA-free inhibitor cocktail can protect phosphorylation-sensitive and native-protein workflows without overstating preclinical findings.
-
Fzd5 Links Cholesterol to Wnt Signaling
2026-09-14
The reference study identifies Frizzled5 (Fzd5) as a cholesterol-sensitive Wnt receptor that connects lipid metabolism with receptor palmitoylation, trafficking, and β-catenin signaling in pancreatic cancer. Its findings suggest that disrupting the cholesterol–Fzd5 interface, including competition by 25-hydroxysterol, may suppress growth in Wnt-dependent pancreatic ductal adenocarcinoma models; see the reference study.
-
Fzd5 Cholesterol Sensing Drives Wnt Signaling in Cancer
2026-09-13
The reference study identifies Frizzled5 as a cholesterol-sensing Wnt receptor that links lipid metabolism to receptor palmitoylation, plasma-membrane trafficking, and pancreatic cancer growth. Its findings provide a mechanistic framework for studying cholesterol-sensitive Wnt signaling and suggest that disrupting the Fzd5–cholesterol interface may be relevant in Wnt-dependent malignancies.
-
AZD1390: ATM Kinase Inhibitor Workflows
2026-09-12
AZD1390 supports mechanism-guided studies of ATM signaling, radiation response, and replication stress across glioma and lung cancer models. This workflow connects nanomolar ATM inhibition with practical assay design and emerging REV1–DHX36 G-quadruplex biology.
-
Cy5 Goat Anti-Mouse IgG: Assay Design
2026-09-11
The Cy5 Goat Anti-Mouse IgG (H+L) Antibody provides a versatile fluorescent readout for mouse primary antibodies. This article explains how to deploy it as an analytical layer in osteogenesis and exosome studies, with emphasis on controls, interpretation, and workflow design.
-
Dicloxacillin Activity Inside and Outside S. aureus
2026-09-11
Sandberg et al. combined a THP-1 intracellular model with a murine peritonitis model to compare dicloxacillin activity against Staphylococcus aureus in intracellular and extracellular compartments. The study showed that free-drug time above the MIC was the most informative PK/PD index in both settings, while differences in sampling time and dosing schedule explained important model discordance.
-
Cell lysis buffer for WB and IP: Lab Guide
2026-09-10
Learn how Cell lysis buffer for WB and IP, SKU K1123, can stabilize protein workflows that follow viability, proliferation, and cytotoxicity assays. This scenario-based guide connects inhibitor-supported, non-denaturing extraction with Western blotting, immunoprecipitation, and tumor-microenvironment research while distinguishing product capabilities from study-specific evidence.
-
Minocycline HCl for EV Inflammation Workflows
2026-09-10
Use Minocycline HCl as a controlled perturbation in extracellular-vesicle, inflammation, and neuroprotection experiments—not merely as an antibiotic. This workflow pairs fresh solution handling, EV-specific controls, and scalable iMSC-EV production concepts to separate drug effects from vesicle-mediated biology.
-
Chronic Cabozantinib Signaling Adaptation in RCC
2026-09-09
This 2026 study uses quantitative phosphoproteomics to distinguish acute from chronic Cabozantinib adaptation in renal cell carcinoma cells. It identifies persistent suppression of activating MET phosphorylation alongside selective adhesion-, stress-, and MAPK/AP-1-associated remodeling, with context-dependent changes in migration and invasion.
-
Bovine Insulin: Cell Culture Mechanisms & Workflow
2026-09-09
Bovine insulin is a double-chain peptide hormone used as a metabolic and trophic supplement in cell culture. Its insulin receptor signaling pathway can support glucose metabolism regulation and cell growth, but product solubility, vehicle controls, and model-specific validation determine experimental reliability.
-
Targeted SPP1 Inhibition in Tumor-Associated Myeloid Cells
2026-09-08
The reference study identifies a phenotypic small-molecule screening strategy for reducing SPP1 expression in tumor-associated macrophages and integrates promising hits into a TAM-avid CANDI nanoformulation. Its lead compound, CANDI460, reduced SPP1 in vitro and in vivo and produced tumor remissions in multiple murine models, offering a framework for tumor microenvironment macrophage modulation.
-
Reserpine (N1867) Lab Workflow Guide
2026-09-08
Reserpine (SKU N1867) is a high-purity research compound for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide covers identity checks, DMSO preparation, storage, and assay QC; the material is for research use only and is not intended for diagnostic, therapeutic, veterinary, or clinical applications.